Privacy StatementTerms Of UseLogin Register
 
HomeCompanyBiotechnologyParticipating BusinessesBusiness ModelInvestment ManagementPress RoomContact
DENdRICO

 

  • Scientific source: Group patents and investigation
  • Main lines: 
    • Transport of siRNA.  Development of a siRNA Transfection  Kit, with competitive advantages, for scientific trials as well as for therapies for different diseases.
    • Transport of medicine to the target organ.
    • Improvement in the efficiency of medicines: alternative routes of administration and dose reduction
    • Formulation of solar filters and dermocosmetics

 
DENDRICO

Technological platform based on carbosilane dendrimer  nanoparticles.

The generic benefits of this technology will be reflected in the reduction of medicine doses, the possibliity of use through less invasive routes, the reduction of side effects and toxicity and  controlled withdrawal from medication in the long-term.